Michihiro Okuyama
Overview
Explore the profile of Michihiro Okuyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito T, Okuyama M, Takahashi Y, Ohkusu K, Yokota K
Cureus
. 2024 Sep;
16(8):e68056.
PMID: 39347232
are generally considered low-pathogenicity organisms but can occasionally cause severe infections. We report a severe case of infective endocarditis caused by complicated by multifocal mycotic aneurysms in an immunocompetent patient...
2.
Kato G, Narumiya Y, Okuyama M, Shimizu S, Sangawa K, Yamamoto S
Acta Med Okayama
. 2024 Aug;
78(4):345-347.
PMID: 39198989
The presence of an intraperitoneal source of infection, e.g., a liver abscess, can be an obstacle to performing an abdominal aortic surgery with a midline laparotomy because graft infection is...
3.
Okuyama M, Jiang W, Yang L, Subramanian V
Circ Rep
. 2021 May;
3(5):259-266.
PMID: 34007939
Ascending and abdominal aortic aneurysms (AAs) are asymptomatic, permanent dilations of the aorta with surgical intervention as the currently available therapy. Hippo-Yap signaling cascade plays a critical role in stem...
4.
Muniappan L, Okuyama M, Javidan A, Thiagarajan D, Jiang W, Moorleghen J, et al.
Arterioscler Thromb Vasc Biol
. 2021 Mar;
41(5):1694-1709.
PMID: 33761765
[Figure: see text].
5.
Okuyama M, Uchida H, Hada Y, Kakio Y, Otaka N, Umebayashi R, et al.
Circ Rep
. 2021 Mar;
1(4):155-161.
PMID: 33693132
Chronic angiotensin II (AngII) infusion promotes ascending aortic dilation in C57BL/6J mice. Meanwhile, vasohibin-2 (VASH2) is an angiogenesis promoter in neovascularization under various pathologic conditions. The aim of this study...
6.
Okuyama M, Jiang W, Javidan A, Chen J, Howatt D, Yang L, et al.
Circulation
. 2020 Nov;
142(20):1993-1995.
PMID: 33196308
No abstract available.
7.
Otaka N, Uchida H, Okuyama M, Hada Y, Onishi Y, Kakio Y, et al.
Am J Hypertens
. 2020 Nov;
34(5):467-475.
PMID: 33180898
Background: Vasohibin-2 (VASH2) has been isolated as a homologue of vasohibin-1 (VASH1) that promotes angiogenesis counteracting with VASH1. Chronic angiotensin II (AngII) infusion promotes both ascending and abdominal aortic aneurysms...
8.
Javidan A, Jiang W, Okuyama M, Thiagarajan D, Yang L, Moorleghen J, et al.
Sci Rep
. 2019 Sep;
9(1):12626.
PMID: 31477775
miR-146a, an anti-inflammatory microRNA, is shown to be a negative regulator of adipocyte inflammation. However, the functional contribution of miR-146a in the development of obesity is not defined. In order...
9.
Kakio Y, Uchida H, Takeuchi H, Okuyama Y, Okuyama M, Umebayashi R, et al.
Geriatr Gerontol Int
. 2018 Oct;
18(12):1597-1602.
PMID: 30311338
Aim: Since 1998, the leading cause of chronic hemodialysis in Japan has been diabetic nephropathy. Diabetes mellitus is known to be a risk factor for frailty, but it still remains...
10.
Takeuchi H, Uchida H, Kakio Y, Okuyama Y, Okuyama M, Umebayashi R, et al.
Aging Dis
. 2018 Jun;
9(2):192-207.
PMID: 29896410
The population undergoing dialysis is aging worldwide, particularly in Japan. The clinical condition of frailty is the most problematic expression in the elderly population. Potential pathophysiological factors of frailty present...